Menü
sharewise zieht um Am Wochenende vom 22./23. August wird das neue sharewise die Hauptseite. Schau es dir jetzt an und sag uns, was dir fehlt. Zum neuen sharewise Was sich ändert
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von conna 

Salesforce.com diskutieren

Salesforce.com

WKN: A0B87V / Symbol: CRM / Name: Salesforce.com / Aktie / Software & Informationsdienstleistungen / Large Cap /

169,36 €
-2,94 %

Einschätzung Buy
Rendite (%) 1,64 %
Kursziel 332,28
Veränderung
Endet am 28.02.25

Salesforce, Inc. (NYSE: CRM) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $360.00 price target on the stock, up previously from $275.00.
Ratings data for CRM provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,64 %
Kursziel 318,44
Veränderung
Endet am 28.02.25

Salesforce, Inc. (NYSE: CRM) had its "buy" rating re-affirmed by analysts at Mizuho. They now have a $345.00 price target on the stock, up previously from $325.00.
Ratings data for CRM provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,57 %
Kursziel 300,27
Veränderung
Endet am 28.02.25

Salesforce, Inc. (NYSE: CRM) had its price target raised by analysts at Wedbush from $280.00 to $325.00. They now have a "buy" rating on the stock.
Ratings data for CRM provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,57 %
Kursziel 332,60
Veränderung
Endet am 28.02.25

Salesforce, Inc. (NYSE: CRM) had its price target raised by analysts at Bank of America Co. from $350.00 to $360.00. They now have a "buy" rating on the stock.
Ratings data for CRM provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,92 %
Kursziel 286,81
Veränderung
Endet am 28.02.25

Salesforce, Inc. (NYSE: CRM) had its price target raised by analysts at JPMorgan Chase & Co. from $260.00 to $310.00. They now have an "overweight" rating on the stock.
Ratings data for CRM provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,71 %
Kursziel 300,69
Veränderung
Endet am 28.02.25

Salesforce, Inc. (NYSE: CRM) had its price target raised by analysts at Royal Bank of Canada from $285.00 to $325.00. They now have an "outperform" rating on the stock.
Ratings data for CRM provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,71 %
Kursziel 305,32
Veränderung
Endet am 28.02.25

Salesforce, Inc. (NYSE: CRM) had its price target raised by analysts at Evercore ISI from $290.00 to $330.00. They now have an "outperform" rating on the stock.
Ratings data for CRM provided by MarketBeat

Einschätzung Buy
Rendite (%) -5,20 %
Kursziel 324,55
Veränderung
Endet am 06.03.25

Salesforce, Inc. (NYSE: CRM) had its price target raised by analysts at Argus from $290.00 to $354.00. They now have a "buy" rating on the stock.
Ratings data for CRM provided by MarketBeat

Einschätzung Buy
Rendite (%) -19,09 %
Kursziel 324,28
Veränderung
Endet am 03.04.25

Salesforce, Inc. (NYSE: CRM) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $350.00 price target on the stock.
Ratings data for CRM provided by MarketBeat

Einschätzung Buy
Rendite (%) -18,34 %
Kursziel 329,04
Veränderung
Endet am 12.04.25

Salesforce, Inc. (NYSE: CRM) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $350.00 price target on the stock, up previously from $325.00.
Ratings data for CRM provided by MarketBeat

Einschätzung Buy
Rendite (%) -17,53 %
Kursziel 323,82
Veränderung
Endet am 15.04.25

Salesforce, Inc. (NYSE: CRM) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $345.00 price target on the stock.
Ratings data for CRM provided by MarketBeat

Einschätzung Buy
Rendite (%) -13,24 %
Kursziel 343,10
Veränderung
Endet am 16.04.25

Salesforce, Inc. (NYSE: CRM) had its "outperform" rating re-affirmed by analysts at Wolfe Research. They now have a $365.00 price target on the stock.
Ratings data for CRM provided by MarketBeat

Einschätzung Buy
Rendite (%) -17,90 %
Kursziel 338,26
Veränderung
Endet am 22.04.25

Salesforce, Inc. (NYSE: CRM) had its price target raised by analysts at Jefferies Financial Group Inc. from $350.00 to $360.00. They now have a "buy" rating on the stock.
Ratings data for CRM provided by MarketBeat

Einschätzung Buy
Rendite (%) -8,65 %
Kursziel 270,00
Veränderung
Endet am 30.06.25

Buy with target price 270.0

Einschätzung Buy
Rendite (%) -4,24 %
Kursziel 322,28
Veränderung
Endet am 24.05.25

Salesforce, Inc. (NYSE: CRM) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $350.00 price target on the stock.
Ratings data for CRM provided by MarketBeat

Einschätzung Buy
Rendite (%) 10,35 %
Kursziel 272,34
Veränderung
Endet am 30.05.25

Salesforce, Inc. (NYSE: CRM) had its price target lowered by analysts at Robert W. Baird from $355.00 to $295.00. They now have an "outperform" rating on the stock.
Ratings data for CRM provided by MarketBeat

Einschätzung Buy
Rendite (%) 10,35 %
Kursziel 295,42
Veränderung
Endet am 30.05.25

Salesforce, Inc. (NYSE: CRM) had its price target lowered by analysts at Morgan Stanley from $350.00 to $320.00. They now have an "overweight" rating on the stock.
Ratings data for CRM provided by MarketBeat

Einschätzung Buy
Rendite (%) 10,32 %
Kursziel 258,50
Veränderung
Endet am 30.05.25

Salesforce, Inc. (NYSE: CRM) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $325.00 to $280.00. They now have an "outperform" rating on the stock.
Ratings data for CRM provided by MarketBeat

Einschätzung Buy
Rendite (%) 10,32 %
Kursziel 318,50
Veränderung
Endet am 30.05.25

Salesforce, Inc. (NYSE: CRM) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $345.00 price target on the stock.
Ratings data for CRM provided by MarketBeat

Einschätzung Buy
Rendite (%) 10,77 %
Kursziel 276,99
Veränderung
Endet am 30.05.25

Salesforce, Inc. (NYSE: CRM) had its price target lowered by analysts at Mizuho from $345.00 to $300.00. They now have a "buy" rating on the stock.
Ratings data for CRM provided by MarketBeat